GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » Issuance of Debt

SDZNY (Sandoz Group AG) Issuance of Debt : $787 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Issuance of Debt?

Sandoz Group AG's Issuance of Debt for the six months ended in Dec. 2024 was $726 Mil.

Sandoz Group AG's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 was $787 Mil.

Sandoz Group AG Issuance of Debt Historical Data

The historical data trend for Sandoz Group AG's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Issuance of Debt Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24
Issuance of Debt
59.00 6,570.00 748.00

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24
Issuance of Debt - 26.00 6,443.00 61.00 726.00

Sandoz Group AG Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $787 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Sandoz Group AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » Issuance of Debt
Comparable Companies
XSWX:GALD XSWX:SFZN XSWX:PPGN XSWX:CURN ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN HKSE:03692 NSE:DIVISLAB XTAE:TEVA ITCI SZSE:000538 UTHR BOM:500087 TSE:4507 SHSE:688506 NSE:TORNTPHARM BOM:543904
Traded in Other Exchanges
SDZXF:USA SDZz:UK 0SAN:UK D8Y0:Germany SDZ:Switzerland
Address
Centralbahnstrasse 4, Basel, CHE, 4051
Website
https://www.sandoz.com
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as the first US biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in its pipeline.